OncoSec Medical, Inc.(NASDAQ : ONCS)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Services » Medical Or Nursing Services
|GH||Guardant Health, Inc.||2.12%||129.67||0.0%||$96.68m|
|OPCH||Option Care Health, Inc.||0.47%||25.67||0.0%||$87.30m|
|CANO||Cano Health, Inc.||-2.27%||15.09||0.0%||$71.79m|
|OSH||Oak Street Health, Inc.||2.92%||53.25||0.0%||$71.14m|
|FLGT||Fulgent Genetics, Inc.||3.43%||89.04||0.6%||$43.03m|
|ONEM||1Life Healthcare, Inc.||3.61%||24.57||0.0%||$35.57m|
|LHCG||LHC Group, Inc.||0.25%||166.00||2.9%||$33.23m|
|ACHC||Acadia Healthcare Co., Inc.||2.02%||60.56||26.8%||$23.98m|
OncoSec Medical, Inc. is a biotechnology company focused on designing, developing and commercializing therapies and proprietary medical approaches to stimulate and to guide an anti-tumor immune response for the treatment of cancer. Its lead product candidate, ImmunoPulse IL-12, uses an electroporation device, with the aim of reversing the immunosuppressive microenvironment in the treated tumor. The company was founded by Avtar S. Dhillon and Punit S. Dhillon on February 8, 2008 and is headquartered inPennington, NJ.